|
Sign In to gain access to subscriptions and/or personal tools.
|
Physiological Regulation of the Secretion of Histatins and Statherins in Human Parotid Saliva
J.L. Jensen
Department of Oral Biology, Faculty of Dentistry, University of Oslo, PO Box 1052 Blindern, 0316 Oslo, Norway
T. Xu
Department of Periodontology and Oral Biology, Boston University School of Graduate Dentistry, Boston
M.S. Lamkin
Department of Periodontology and Oral Biology, Boston University School of Graduate Dentistry, Boston
P. Brodin
Department of Oral Biology, Faculty of Dentistry, University of Oslo, PO Box 1052 Blindern, 0316 Oslo, Norway
H. Aars
Department of Oral Biology, Faculty of Dentistry, University of Oslo, PO Box 1052 Blindern, 0316 Oslo, Norway
T. Berg
Department of Physiology, Institute of Basic Medical Research, Medical Faculty, University of Oslo, Norway
EG Oppenheim
Department of Periodontology and Oral Biology, Boston University School of Graduate Dentistry, Boston
The small salivary phosphoproteins, histatins and statherins, have important functions in the oral cavity in terms of antimicrobial actions and regulation of calcium phosphate homeostasis. Neither the effects of various physiological stimuli on their secretion nor the nature of the efferent receptor involved in the stimulus-secretion coupling has been determined previously. These aspects are important for improved understanding of the secretory control of salivary proteins and may have implications regarding the effects of specific medications on salivary constituents and oral health.
The effects of graded mechanical (chewing on short and long silicone tubings) and gustatory stimulation (0.5, 1.5, and 5.0% citric acid) on the secretion of histatins and statherins were studied in the presence and absence of adrenolytic agents (n = 10). In this model, secretory rates of both proteins increased with increases in flow rate, with 5.0% citric acid representing a particularly potent stimulus. Histatin and statherin secretory rates were significantly reduced by the β 1-adrenolytic agent (histatins to 58 to 72% and statherins to 11 to 29% of that in corresponding control experiments), but not by the 1-adrenolytic agent. Since the β1-adrenergic receptors played an important role in the stimulus-secretion coupling of these proteins, protective salivary functions in the oral cavity may be compromised during β 1-adrenolytic treatment.
Key Words: Alpha Adrenergic Receptor Antagonists Beta Adrenergic Receptor Antagonists Parotid Gland Reflex Stimulation Salivary Proteins.
Journal of Dental Research, Vol. 73, No. 12,
1811-1817 (1994)
DOI: 10.1177/00220345940730120401

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati Twitter What's this?
This article has been cited by other articles:

|
 |

|
 |
 
M. Ahmad, M. Piludu, F. G. Oppenheim, E. J. Helmerhorst, and A. R. Hand
Immunocytochemical Localization of Histatins in Human Salivary Glands
J. Histochem. Cytochem.,
March 1, 2004;
52(3):
361 - 370.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Gusman, J. Travis, E. J. Helmerhorst, J. Potempa, R. F. Troxler, and F. G. Oppenheim
Salivary Histatin 5 Is an Inhibitor of Both Host and Bacterial Enzymes Implicated in Periodontal Disease
Infect. Immun.,
March 1, 2001;
69(3):
1402 - 1408.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Nederfors
Xerostomia and Hyposalivation
Advances in Dental Research,
December 1, 2000;
14(1):
48 - 56.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
J. C. ATKINSON, A. O'CONNELL, and D. AFRAMIAN
ORAL MANIFESTATIONS OF PRIMARY IMMUNOLOGICAL DISEASES
J Am Dent Assoc,
March 1, 2000;
131(3):
345 - 356.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. M. Cole, P. Dewan, and T. Ganz
Innate Antimicrobial Activity of Nasal Secretions
Infect. Immun.,
July 1, 1999;
67(7):
3267 - 3275.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E.J. Helmerhorst, R. Hodgson, W. van't Hof, E.C.I. Veerman, C. Allison, and A.v. Nieuw Amerongen
The Effects of Histatin-derived Basic Antimicrobial Peptides on Oral Biofilms
Journal of Dental Research,
June 1, 1999;
78(6):
1245 - 1250.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Nordgarden, M. Lamkin, E. Oppenheim, K. Storhaug, and J.L. Jensen
Salivary Secretions: Narcolepsy and Central Nervous System Stimulants
Journal of Dental Research,
October 1, 1998;
77(10):
1817 - 1822.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Tsai and L.A. Bobek
Human Salivary Histatins: Promising Anti-Fungal Therapeutic Agents
Critical Reviews in Oral Biology & Medicine,
January 1, 1998;
9(4):
480 - 497.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. Iontcheva, F.G. Oppenheim, and R.F. Troxler
Human Salivary Mucin MG1 Selectively Forms Heterotypic Complexes with Amylase, Proline-rich Proteins, Statherin, and Histatins
Journal of Dental Research,
March 1, 1997;
76(3):
734 - 743.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
J.D. Rudney
Does Variability in Salivary Protein Concentrations Influence Oral Microbial Ecology and Oral Health?
Critical Reviews in Oral Biology & Medicine,
January 1, 1995;
6(4):
343 - 367.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|
|